A new study from the Spanish National Cancer Research Centre shows that a triple combination therapy can eliminate pancreatic tumours in mice and prevent recurrence, offering hope for improving survival rates in patients with pancreatic ductal adenocarcinoma. The research highlights the importance of targeting multiple points in the KRAS oncogene pathway to avoid treatment resistance. While promising, the authors caution that clinical trials are not yet feasible. Teljes cikk (Euronews.com)